Both blood and urine tests are simple tests that can be done in a doctor's office or clinic. These tests can be done on even the youngest patients. A newborn can be tested by blood or urine, however urine is more accurate in diagnosing organic acidemia hence, more reliable. The screening spectrum by urine covers more than 100 metabolic disorders across carbohydrate, fat and amino acid metabolism.
The biggest precaution be the accuracy of the test. When a test is done it should be more sensitive and specific, if not can result in false positive and false negative result. The sensitivity of a test depends to a large extent on chosen cut-off values, and is a balancing act: the higher the sensitivity the lower the specificity. The sensitivity and specificity of course will vary according to decisions about cut-off
points and what range of false positive and negative results can be tolerated in a particular programme.
Amino acid disorder screening is done in newborns, and sometimes children and adults, to detect inborn errors in metabolism of amino acids. The initial aim of newborn screening is to identify infants with serious but treatable genetic metabolic disorders, so as to facilitate interventions to prevent or ameliorate the clinical consequences of the disease. In recent years, with the advent of newer technologies like bloob spot based tandem mass-spectrometry and urine based gas chromatography and mass spectrometry GC-MS which can detect as many as more than 100 disorders, and hence has the ability of early detection for early treatment.
Two types of amino acid screening tests are used together to diagnose amino acid disorders.Blood plasma screening.Urine test.Both these tests use thin layer chromatography to separate the amino acids present.
The pattern of amino acid banding on the thin layer chromatography plates will be normal.
Amino acid disorder screening checks for inherited disorders in amino acid metabolism. Tests are most commonly done on newborns. Two tests are available, one using a blood sample and the other a urine sample. Newborn screening was first applied to the detection of phenylketonuria (PKU) by a bacterial inhibition assay pioneered in 1961 by Guthrie, who was also responsible for the introduction of the use of a dried blood sample. This was followed by further bacterial inhibition assays to detect other aminoacidopathies (maple syrup urine disease, homocystinuria, urea cycle disorders and so on) but only screening for PKU was widely adopted. In 1975 Dussault described screening for congenital hypothyroidism (CH), and since then other disorders covered in some screening programmes have included congenital adrenal hyperplasia, the galactosaemias, cystic fibrosis, biotinidase deficiency, glucose-6-phosphate dehydrogenase deficiency and many others. The application of GCMS technology has changed the diagnostics in metabolic disorders giving accurate results from a urine test. This new technology has greatly changed both newborn screening and the diagnosis of as many as 100 treatable inborn errors of metabolism including the amino acid metabolism.
.In the event of abnormal results, there are many other tests that will be performed to determine the specific amino acid involved in the abnormality.
Urine test is a painless procedure....not painful the urine test which ur asking is a confirmatory test for metabolic testing and not screening ....screening is to identify high risk cases by urine u get diagnostic results for amino acid metabolic disorders..... and no urine tests are not painful its the heel prick test which is very painful for the baby
The blood plasma amino acid pattern is abnormal in overflow aminoaciduria and is normal in renal aminoaciduria. The pattern is abnormal in the urine test, suggesting additional tests need to be done to determine which amino acids are involved.
To eat a wide range of fruits and vegetables.
l-tryptophan is not a disorder-it is an amino acid used by some people to help them sleep! that being said, it can cause a type of blood disorder if it isn't properly produced
Maple Syrup Urine Disease (MSUD) was discovered by John Menkes in 1954. This is a disorder whereby there is a disruption in the metabolism of branched-chained amino acids.
tryptophan
Before the blood test, the patient must not eat or drink for four hours.The patient should eat and drink normally before the urine test.The technician handling the urine sample should be informed of any medications the patient is taking.